| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-38 |
| filingDate |
2002-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab39c3f63404d78655c68c3aa454fc47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2417b675b5947931046d1382618b123b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0706340e70548faf9722586c7cbcec4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fa3ffcae55f38ea3a2668c50305acaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b3923600ad690e131e14376d89170bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5550fb89dcb7b6205fed33c8dab66476 |
| publicationDate |
2005-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6943162-B2 |
| titleOfInvention |
Piperazinyltriazines as estrogen receptor modulators |
| abstract |
Triazine derivatives of formula (I), which exhibit pharmacological activity at estrogen receptors alpha (ER alpha) and beta (ER beta) are described herein. The described invention also includes compositions and medicaments containing the triazine derivatives as well as processes for the preparation and use of such compounds, compositions and medicaments. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9604931-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010014744-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100761869-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9078888-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9623021-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010267767-A1 |
| priorityDate |
2001-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |